Skip to main content

Epidemiology of Atrial Fibrillation The Rising Prevalence

  • Chapter

Part of the book series: Contemporary Cardiology ((CONCARD))

Abstract

The prevalence of atrial fibrillation (AF) is increasing worldwide, resulting in a cardiovascular “epidemic.” The rise in the prevalence of AF can be predominantly attributed to aging of the population and a higher incidence of cardiovascular diseases. The reasons for the increase in prevalence of AF has yet to be completely elucidated; age, gender, race, and cardiovascular disease have been shown to correlate with AF prevalence. It is estimated that AF affects 2.2 million individuals in the United States. However, the prevalence of AF may be underestimated because of a large number of asymptomatic individuals. It is projected that the aging of the population will result in 2.5-fold rise in the prevalence of AF by 2050. When considering both the aging of the population and the prevalence of AF, preventive measures that reduce the incidence of AF will have substantial economic and societal benefits.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. 1. Braunwald E. Shattuck lecture—cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities.N Engl J Med. 1997;337(19):1360–1369.

    Article  Google Scholar 

  2. 2. Wolf PA, Benjamin EJ, Belanger AJ, Kannel WB, Levy D, D'Agostino RB. Secular trends in the prevalence of atrial fibrillation: the Framingham Study. Am Heart J. 1996;131(4):790–795.

    Article  CAS  PubMed  Google Scholar 

  3. U.S. Census Bureau. Projections of the total resident population by 5-year age groups and sex with special age categories: middle series, 2050 to 2070. Washington, DC: Population Projections Program, Population Division, U.S. Census Bureau; 2000.

    Google Scholar 

  4. 4. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC, Klein WW, Alonso-Garcia A, Blomstrom-Lundqvist C, De Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A. American College of Cardiology/American Heart Association/ European Society of Cardiology Board. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences. J Am Coll Cardiol. 2001;38(4):1231–1266.

    Article  CAS  PubMed  Google Scholar 

  5. 5. Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR Jr, Ilstrup DM, Frye RL. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med. 1987;317(11):669–674.

    Article  CAS  PubMed  Google Scholar 

  6. 6. Kopecky SL, Gersh BJ, McGoon MD, Chu CP, Ilstrup DM, Chesebro JH, Whisnant JP. Lone atrial fibrillation in elderly persons: a marker for cardiovascular risk. Arch Intern Med. 1999;159(10):1118–1122.

    Article  CAS  PubMed  Google Scholar 

  7. 7. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health. 1951;41(3):279–281.

    Article  CAS  Google Scholar 

  8. 8. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994;271(11):840–844.

    Article  CAS  PubMed  Google Scholar 

  9. 9. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983–988.

    CAS  PubMed  Google Scholar 

  10. 10. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997;96(7):2455–2461.

    CAS  PubMed  Google Scholar 

  11. 11. Lake FR, McCall MG, Cullen KJ, Rosman DL, de Klerk NH. Atrial fibrillation and mortality in an elderly population. Aust N Z J Med. 1989;19:321–326.

    CAS  PubMed  Google Scholar 

  12. 12. Phillips SJ, Whisnant JP, O'Fallon WM, Frye RL. Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota. Mayo Clin Proc. 1990;65(3):344–359.

    CAS  PubMed  Google Scholar 

  13. 13. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol. 1994;74(3):236–241.

    Article  CAS  PubMed  Google Scholar 

  14. 14. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med. 1995;155(5):469–473.

    Article  CAS  PubMed  Google Scholar 

  15. 15. Stewart S, Hart CL, Hole DJ, McMurray JJ. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart. 2001;86(5):516–521.

    Article  CAS  PubMed  Google Scholar 

  16. 16. Majeed A, Moser K, Carroll K. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994–1998: analysis of data from the general practice research database. Heart. 2001;86(3):284–288.

    Article  CAS  PubMed  Google Scholar 

  17. 17. Boysen G, Nyboe J, Appleyard M, Sorensen PS, Boas J, Somnier F, Jensen G, Schnohr P. Stroke incidence and risk factors for stroke in Copenhagen, Denmark. Stroke. 1988;19(11):1345–1353.

    CAS  PubMed  Google Scholar 

  18. 18. Onundarson PT, Thorgeirsson G, Jonmundsson E, Sigfusson N, Hardarson T. Chronic atrial fibrillation—epidemiologic features and 14 year follow-up: a case control study. Eur Heart J. 1987;8(5):521–527.

    CAS  PubMed  Google Scholar 

  19. 19. Langenberg M, Hellemons BS, van Ree JW, Vermeer F, Lodder J, Schouten HJ, Knottnerus JA. Atrial fibrillation in elderly patients: prevalence and comorbidity in general practice. Br Med J. 1996;313(7071):1534.

    CAS  Google Scholar 

  20. 20. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370–2375.

    Article  CAS  PubMed  Google Scholar 

  21. 21. Go AS. The epidemiology of atrial fibrillation in elderly persons: the tip of the iceberg. Am J Geriatr Cardiol. 2005;14:56–61.

    Article  PubMed  Google Scholar 

  22. 22. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA. 2003;290(2):199–206.

    Article  PubMed  Google Scholar 

  23. American Heart Association. 2002 Heart and stroke statistical update. Dallas, TX: American Heart Association; 2001.

    Google Scholar 

  24. 24. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care. 1998;21(4):518–524.

    Article  CAS  PubMed  Google Scholar 

  25. 25. Ruo B, Capra AM, Jensvold NG, Go AS. Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study. J Am Coll Cardiol. 2004;43(3):429–435.

    Article  PubMed  Google Scholar 

  26. 26. Ryder KM, Benjamin EJ. Epidemiology and significance of atrial fibrillation. Am J Cardiol. 1999;84(9A):131R–138R.

    Article  CAS  PubMed  Google Scholar 

  27. 27. Conway DS, Lip GY. Ethnicity in relation to atrial fibrillation and stroke (the West Birmingham Stroke Project). Am J Cardiol. 2003;92(12):1476–1479.

    Article  PubMed  Google Scholar 

  28. 28. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med. 1982;306(17):1018– 1022.

    Article  CAS  PubMed  Google Scholar 

  29. 29. Healey JS, Connolly SJ. Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target. Am J Cardiol. 2003;91(10A):9G–14G.

    Article  PubMed  Google Scholar 

  30. 30. Levy S, Maarek M, Coumel P, Guize L, Lekieffre J, Medvedowsky JL, Sebaoun A. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. Circulation. 1999;99(23):3028–3035.

    CAS  PubMed  Google Scholar 

  31. 31. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation. 1994;89(2):724–730.

    CAS  PubMed  Google Scholar 

  32. 32. Tsang TS, Gersh BJ, Appleton CP, Tajik AJ, Barnes ME, Bailey KR, Oh JK, Leibson C, Montgomery SC, Seward JB. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol. 2002;40(9):1636–1644.

    Article  PubMed  Google Scholar 

  33. 33. Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE, Malouf JF, Ammash NM, Friedman PA, Somers VK. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004;110(4):364–367.

    Article  PubMed  Google Scholar 

  34. 34. Auer J, Scheibner P, Mische T, Langsteger W, Eber O, Eber B. Subclinical hyper-thyroidism as a risk factor for atrial fibrillation. Am Heart J. 2001;142(5):838– 842.

    Article  CAS  PubMed  Google Scholar 

  35. 35. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, Tracy RP, Van Wagoner DR, Psaty BM, Lauer MS, Chung MK. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003;108(24):3006–3010.

    Article  PubMed  Google Scholar 

  36. 36. Eaker ED, Sullivan LM, Kelly-Hayes M, D'Agostino RB Sr, Benjamin EJ. Anger and hostility predict the development of atrial fibrillation in men in the Framingham Offspring Study. Circulation. 2004;109(10):1267–1271.

    Article  PubMed  Google Scholar 

  37. 37. Brugada R, Tapscott T, Czernuszewicz GZ, Marian AJ, Iglesias A, Mont L, Brugada J, Girona J, Domingo A, Bachinski LL, Roberts R. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med. 1997;336:905–911.

    Article  CAS  PubMed  Google Scholar 

  38. 38. Darbar D, Herron KJ, Ballew JD, Jahangir A, Gersh BJ, Shen WK, Hammill SC, Packer DL, Olson TM. Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol. 2003;41(12):2185–2192.

    Article  PubMed  Google Scholar 

  39. 39. Chen YH, Xu SJ, Bendahhou S, Wang XL, Wang Y, Xu WY, Jin HW, Sun H, Su XY, Zhuang QN, Yang YQ, Li YB, Liu Y, Xu HJ, Li XF, Ma N, Mou CP, Chen Z, Barhanin J, Huang W. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science. 2003;299(5604):251–254.

    Article  CAS  PubMed  Google Scholar 

  40. 40. Ellinor PT, Shin JT, Moore RK, Yoerger DM, MacRae CA. Locus for atrial fibrillation maps to chromosome 6q14–16. Circulation. 2003;107(23):2880–2883.

    Article  PubMed  Google Scholar 

  41. 41. Ellinor PT, Macrae CA. The genetics of atrial fibrillation. J Cardiovasc Electrophysiol. 2003;14(9):1007–1009.

    Article  PubMed  Google Scholar 

  42. 42. Haupt BJ, Graves EJ. Detailed diagnosis and procedures for patients discharged from short-stay hospitals. United States, 1979. Department of Health and Human Services publication no. (PHS) 82-1274-1. Hyattsville, MD: National Center for Health Statistics; 1982.

    Google Scholar 

  43. 43. Graves EJ. Detailed diagnosis and procedures. National Hospital Discharge Survey, 1992, Vital Health Statistics (13). Hyattsville, MD: National Center for Health Statistics; 1994 (118).

    Google Scholar 

  44. 44. Friberg J, Scharling H, Gadsboll N, Jensen GB. Sex-specific increase in the prevalence of atrial fibrillation (the Copenhagen City Heart Study). Am J Cardiol. 2003;92(12):1419–1423.

    Article  PubMed  Google Scholar 

  45. 45. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995;98(5):476–484.

    Article  CAS  PubMed  Google Scholar 

  46. 46. Ruigomez A, Johansson S, Wallander MA, Rodriguez LA. Incidence of chronic atrial fibrillation in general practice and its treatment pattern. J Clin Epidemiol. 2002;55(4):358–363.

    Article  PubMed  Google Scholar 

  47. 47. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, D'Agostino RB, Massaro JM, Beiser A, Wolf PA, Benjamin EJ. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110(9):1042– 1046.

    Article  PubMed  Google Scholar 

  48. 48. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98(10):946–952.

    CAS  PubMed  Google Scholar 

  49. Anonymous. Preliminary report of the Stroke Prevention in Atrial Fibrillation Study. N Engl J Med. 1990;322(12):863–868.

    Google Scholar 

  50. 50. Padanilam BJ, Prystowsky EN. New antiarrhythmic agents for the prevention and treatment of atrial fibrillation. J Cardiovasc Electrophysiol. 2006;17(s3):S62–S66.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Padanilam, B.J., Prystowsky, E.N. (2008). Epidemiology of Atrial Fibrillation The Rising Prevalence. In: Natale, A., Jalife, J. (eds) Atrial Fibrillation. Contemporary Cardiology. Humana Press. https://doi.org/10.1007/978-1-59745-163-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-163-5_1

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-856-0

  • Online ISBN: 978-1-59745-163-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics